Objective: To determine the association between initial screen result and returning for a second screen in an organised breast screening programme for women with a biennial screening recommendation.
I
n 2001, breast cancer was diagnosed in an estimated 7200 Ontario women and an estimated 2100 women will die from the disease. I Relative survival after diagnosis of breast cancer has been improving over time in Ontario." Evidence of a reduction in breast cancer mortality rate through screening comes from the results of several randomised controlled trials and subsequent meta-analyses of these trials.':" The Canadian Task Force on the Periodic Health Examination recommends screening for breast cancer by mammography and clinical breast examination (CBE) every one to two years for women aged 50-69. 5 In Ontario most medical services are covered under the provincially managed universal health insurance plan (OHIP). Only diagnostic mammography was an insured service under ORIP prior to 1990. In 1990, the Independent Health Facilities Act allowed for the establishment and licensing of private diagnostic radiology clinics and the existing mammography billing code could also be used for screening mammograms. At the same time, the Ministry of Health established the Ontario Breast Screening Program (OBSP), under the auspices of Cancer Care Ontario to deliver an organised breast screening programme within the publicly funded health care system. In Ontario, therefore, women can receive a screening mammogram through physician or self-referral to OBSP or through physician referral to an independent radiologist.
Results from randomised controlled breast screening trials have shown that a significant reduction in mortality can only be achieved after 7-10 years of regular attendance by 70% of the women in the target age group."? An understanding of how various factors are associated with reattendance at screening is important for targeting appropriate strategies to encourage regular participation. Several factors have been found to be associated with reattendance such as www.jmedscreen.com age, physician recommendation, prior mammography use, knowing the preventive role of mammography, and initial screen result.
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A false-positive result at an initial screening examination may be a factor of particular importance affecting regular attendance because the estimated cumulative risk of a falsepositive result is about 50% after 10 mammograms and 22% after 10 CBEs.
12 Several studies have shown that a falsepositive mammogram result can cause anxiety, distress and intrusive thoughts, which may persist for several months and/or years after completion of assessment. 13-1 5 In addition, the intensity of the adverse psychological consequences is dependent on the type and extent of the further investigation, with greatest anxiety being reported by women who undergo a benign biopsy or women who are placed on early recall.":"
Population-based studies examining the relationship between compliance with rescreening and a false-positive screen have found conflicting results. A few studies have found an abnormal mammogram to be associated with a lower compliance with rescreening.v" These studies suggested that some women requiring breast assessment procedures after an abnormal result might have remained with diagnostic radiological services for subsequent screening. Results from other studies have found either no association or an increased association between falsepositive screening results and rates of reattendance.I'v'r" Two of these studies involved screening programmes linked with assessment programmes, thus allowing women with false-positive screen results to be followed within the screening programmes.
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In the other study, women were screened with both CBE and mammography.'?
In Ontario, as in most of Canada, diagnostic assessment is usually coordinated by the family physician and women are assessed through community diagnostic facilities.":" However, during the time period of this study the OBSP had operated an integrated comprehensive assessment programme at one of its screening centres, with a multidisciplinary team of radiologists, surgeons and pathologists. For the remainder of the women within the OBSP, their family physicians initiate and coordinate their assessment process. Therefore, the OBSP provides a unique opportunity to determine whether reattendance differs by integration of screening services with an assessment programme. While the OBSP has a higher false-positive rate compared with organised screening programmes that offer only mammography, this rate is similar to other Canadian screening programmes that offer both CBE and mammography." Therefore the OBSP can also provide a distinct comparison of reattendance after an abnormal initial screen result by modality of referral.
The purpose of this retrospective cohort study was to determine the association between initial screen result and returning for a second screen in an organised screening programme for women with a biennial screening recommendation. Women were compared by age at initial screen, year of screen and region (within Ontario). In addition, the present study also examined whether the rate of reattendance by initial screen result differed by integration of OBSP centre with an assessment programme and by modality of referral.
METHODS

Study population
The study population included 140,723 Ontario women aged 50 years and older who had an initial screen at OBSP between 1 July 1990 to 31 December 1995, and were followed until 30 June 1998. From 1990 to 1994, screening took place in eight regional hub centres across Ontario and in one mobile unit, targeting communities in the northwestern region of the province. Over the time period of the study, an additional 18 established mammography facilities in hospitals or clinics began providing OBSP screens. The OBSP, a provincial population-based screening programme, offers eligible women aged 50 years or older biennial screening consisting of two-view mammography and CBE by a trained nurse. While women over 50 are eligible for screening, only women aged 50-69 are actively recruited. Women are not eligible if they had a prior history of breast cancer or augmentation mammoplasty, or if they currently had symptoms of breast disease. A complete description of the operation of OBSP has been previously published."
Although a select group of women who lived in close proximity to some of the screening centres were sent personalised letters of invitation during the first two years of the programme, the majority of women who attended OBSP Chiarelli, Maravan, Halapy, et 0/.
for their initial screen were not sent personal invitations. The programme was promoted to women primarily by their family physicians, in addition to media campaigns, community presentations and through public health units. Therefore, women could either self-refer or be referred by their family physicians. Recall letters were sent to all eligible women two months before their second screening visit to remind them to return for screening. Generation of recall letters was carried out at the regional level with the support of a computerised client management system.
As the purpose of this study was to examine compliance with biennial screening, women considered to be at high risk for breast cancer and given an annual rescreening recommendation (n=4434, 3%) were excluded. In addition, women who were diagnosed with breast cancer on their first screen or in the interval prior to their second screen or who died were excluded (Table 1 ). All breast cancers were confirmed by pathology. Information on women diagnosed with breast cancers (screen and interval-detected) was obtained through the recall process and through linkages with the Ontario Cancer Registry (OCR). Analyses of the completeness of OCR have suggested a very high level of completeness in case ascertainment for breast cancer." Identification of vital status of participants was accomplished by a record linkage with the Ontario Registrar General's mortality file. As registration of death is a legal process in Ontario, this ensured that all deaths were registered." All of the record linkages were done using a PC-based computerised probabilistic record linkage system known as Autovtatch."
Initial screen result characteristics
The age of the woman, year of screen, region (within Ontario) and screening result were the characteristics related to the client's initial screen that were compared. Year of initial screen refers to the first year the woman was screened at OBSP. As the number of screens in 1990 was very small, occurring only in the latter half of the year and exclusively from one centre, initial screens from 1990 were combined with those from 1991. The regional hub centres and associated affiliated sites were grouped according to eight designated cancer treatment services and planning regions that covered the entire province.
The result of an initial screen can be either normal or abnormal. In this study, an abnormal result was considered a false-positive result as only women referred for further assessment without a breast cancer diagnosis were included. A referral may result independently from a clinical finding detected by the nurse examiner or a mammographic finding detected by the radiologist. Therefore, abnormal initial screen results were categorised by modality of referral: CBE alone (abnormal CBE, normal mammogram), mammogram alone (abnormal mammogram, normal CBE) and CBE and mammogram (abnormal CBE, abnormal mammogram). Initial screen results were also examined by whether the women were screened at an OBSP centre with or without an assessment programme. Only women with an initial screen result at the Hamilton centre, the only OBSP hub with an on-site multidisciplinary assessment clinic, were classified as being screened at an OBSP centre with an assessment programme.
Statistical analysis
The proportion of women who returned for rescreening in the study was calculated as the number of women who had returned for rescreening in the selected time period, from those eligible for rescreening at that time. The actuarial survival method was used to examine the rate of rescreen at 36 months, weighted by 10-year age groups, and the cumulative probability of being rescreened over time. The timing of repeat screens was assessed by estimating the daily rates of repeat screening by time since first programme screen.
To account for variable entry points and length of time to end of follow-up, a stratified Cox-proportional hazards regression model was used to estimate the likelihood of returning for rescreening at any point in time." The common risk ratio estimates and their 95% confidence intervals were calculated for each characteristic. Models were stratified by l O-year age groups to account for different age distributions within categories. Time of follow-up was calculated as the number of days between the initial screen and the end of follow-up. End of follow-up was date of diagnosis of breast cancer, date of death, return date to OBSP or end of study, whichever occurred first. Statistical analyses were performed using SAS software."
RESULTS
Of the women eligible for rescreening, 68.6% returned at 30 months after their initial screen, 72.0% returned at 36 months, 73.9% returned at 42 months and 78.1 % returned for a second screen at any time (Table 1) . The rescreening rate decreased with age at initial screen, being highest for women aged 50-59 (73.0%) and lowest for women aged 75 years and older (59.8%) ( Table 2 ). Women aged 70-74 and 75 years of age and older were significantly less likely to return to screening in comparison with women aged 50-59. There was little variation in rescreening rates over time. Table 3 ). For initial screen results, returning for a second screen was stratified by integration of OBSP centre with an assessment programme and by modality of referral. As seen overall, at OBSP centres without an assessment programme, women referred with an abnormality were significantly less likely to return than women with a normal result. However, at the OBSP centre with an assessment programme, the rescreening rates were similar for women with a normal screen result and a referred mammographic abnormality alone (74.0%), and were slightly higher for those with a 
DISCUSSION
Figure 1 Cumulative probability of having a second screen by result of initial screen. 
ACKNOWLEDGEMENTS
programmes in the United Kingdom and Australia found no association between false-positive screening results and rates of reattendance.
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In these countries diagnostic assessment after an abnormality remains the responsibility of the screening programme, and interdisciplinary assessment clinics are affiliated with screening centres. 28 .
29 At the only OBSP centre with an integrated comprehensive assessment programme, women with abnormal initial results also had a similar likelihood of returning to screening as women with normal screen results. Therefore, a false-positive result did not reduce subsequent screening behaviour in screening programmes that were integrated with assessment services.
It has been suggested that a decrease in compliance after a false-positive finding may result from psychological distress experienced by the women, especially if the women undergo a benign biopsy." In general, women with referred clinical abnormalities alone in the OBSP have fewer invasive assessment procedures such as biopsies as part of their diagnostic assessment. This may partially explain why women with a referred clinical abnormality alone were more likely to return than women with a referred mammographic abnormality (with or without an abnormal clinical finding) in OBSP centres without an assessment programme. However, there were minimal differences between reattendance by modality of referral in the OBSP centre with an assessment programme. Therefore it seems more likely that any differences by modality of referral at OBSP centres without an assessment programme occur as women with referred clinical abnormalities are less likely to remain in the diagnostic system for subsequent screening.
The main limitation of this study was lack of access to data on screening mammograms outside of the OBSP for women who did not return after their initial screen. Therefore it was not possible to determine whether women who did not return to the OBSP accessed mammography facilities outside of the organised screening programme. Although this is an important consideration in analysing factors associated with compliance with rescreening, the aim of the present study was to examine compliance with rescreening within an organised screening programme which offers the essential components of recruitment and automatic recall. These services are not offered by mammography facilities that are not OBSP sites.
An advantage of the present study included the use of routine data collected on women screened in OBSP, which is an objective measure of behaviour regarding reattendance. Furthermore, this study examined factors that have not been previously examined, namely, screening result by modality of referral and by integration of screening services with an assessment programme.
A high rate of reattendance to breast screening programmes is important in achieving a reduction in breast cancer mortality. Although this study found that women with a false-positive result were less likely to return to screening, this finding was seen only for women screened at centres without an assessment programme. Therefore organised breast screening programmes should integrate screening and assessment services as a strategy to increase compliance with rescreening for women with a false-positive result. Currently, the OBSP is implementing a number of initiatives to integrate the breast screening programme with assessment services throughout the province.
The authors wish to thank Mrs Sylvia Shedden for reviewing the manuscript. This retrospective cohort study examined the association between initial screen result and returning for a second screen in an organised screening programme. Overall, 78.1 % of women who attended OBSP for an initial screen returned for a subsequent screen and there were only slight variations in compliance by the year of the initial screen. Similar to our investigation, other studies have also shown that younger age is associated with a greater likelihood of returning to screening.v' 1.26 This may confirm the effectiveness of the OBSP strategy to actively recruit women aged 50-69 for regular breast screening, although all women over 50 years of age were sent recall letters. Other studies have suggested that decreasing compliance with increasing age may be directly related to poorer health or increasing difficulty travelling to screening centres. I 1. 26 Regional variation in compliance with rescreening was evident, as women living in both the largest (5,484,173 in Central East) and smallest (373,008 in South) regions of Ontario had the lowest likelihood of returning to screening." Therefore, size of population did not explain the lower reattendance rates. Instead, this may be related to the number of facilities where mammography is available, with fewer established mammography facilities affiliated with the OBSP in these regions during this time period.
Having a false-positive initial screen result was associated with a decreased likelihood of returning for a second screen in the present study at centres without an assessment programme, especially if the referred abnormality was mammographic. This finding was consistent with those from two other studies analysing compliance in population-based screening programmes in British Colombia and the Netherlands.v" Both of these studies suggested that women might continue to be screened in diagnostic radiological facilities after a false-positive screen result. Results from two other studies using data from population-based breast screening referred clinical abnormality alone (76.9%) or referred mammographic and clinical abnormality (76.9%). Figure 1 shows the cumulative probability of returning for a second screen by result of initial screen. The probability of rescreening begins to increase rapidly between 22 and 24 months and then levels off, irrespective of the result of initial screen. Women referred on the basis of a mammographic finding, whether alone or with a clinical finding, were less likely to return. The failure function shows this difference to be consistent across the entire time period of the study.
